標(biāo)題: Titlebook: Medical Imaging in Clinical Trials; Colin G. Miller,Joel Krasnow,Lawrence H. Schwartz Book 2014 Springer-Verlag London 2014 Ultrasonograph [打印本頁(yè)] 作者: PED 時(shí)間: 2025-3-21 18:55
書目名稱Medical Imaging in Clinical Trials影響因子(影響力)
書目名稱Medical Imaging in Clinical Trials影響因子(影響力)學(xué)科排名
書目名稱Medical Imaging in Clinical Trials網(wǎng)絡(luò)公開(kāi)度
書目名稱Medical Imaging in Clinical Trials網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Medical Imaging in Clinical Trials被引頻次
書目名稱Medical Imaging in Clinical Trials被引頻次學(xué)科排名
書目名稱Medical Imaging in Clinical Trials年度引用
書目名稱Medical Imaging in Clinical Trials年度引用學(xué)科排名
書目名稱Medical Imaging in Clinical Trials讀者反饋
書目名稱Medical Imaging in Clinical Trials讀者反饋學(xué)科排名
作者: SHOCK 時(shí)間: 2025-3-21 22:02 作者: 好忠告人 時(shí)間: 2025-3-22 03:04 作者: Mercantile 時(shí)間: 2025-3-22 08:14 作者: Repatriate 時(shí)間: 2025-3-22 11:53
Cardiac Imaging in Clinical Trialsequires knowledge of the relevant imaging technologies and their relative strengths and weaknesses. Cardiovascular imaging can be approached from either an anatomic or a physiological perspective. This chapter is organized by disease process with discussion of the current and evolving imaging standards.作者: Palpable 時(shí)間: 2025-3-22 15:53 作者: 控制 時(shí)間: 2025-3-22 17:04
978-1-84882-709-7Springer-Verlag London 2014作者: A保存的 時(shí)間: 2025-3-22 22:07
Radiation Risks and Dosimetry Assessmentnd the impact on trial participants. Communicating the radiation risk to patients is always difficult, and the chapter suggests some possible comparisons that may be useful in the patient information.作者: antedate 時(shí)間: 2025-3-23 03:02
Neuroimaging in Clinical Trialsrement criteria used to evaluate investigations in neuro-oncology, stroke, multiple sclerosis, and Alzheimer’s disease. This chapter will also provide a brief review of these pathologies to provide a better understanding of the topics most commonly investigated with neuroimaging.作者: Psychogenic 時(shí)間: 2025-3-23 06:52 作者: Interdict 時(shí)間: 2025-3-23 09:48 作者: Communicate 時(shí)間: 2025-3-23 16:27 作者: 駁船 時(shí)間: 2025-3-23 19:16 作者: headlong 時(shí)間: 2025-3-23 23:20 作者: covert 時(shí)間: 2025-3-24 05:47
idly increasing use of medical imaging in clinical trials, through all phases. More recently this has culminated in a number of inter-disciplinary meetings with the various stake holders, including the FDA.?Changes in the regulatory process has resulted, when it comes to the submission of data to th作者: 釋放 時(shí)間: 2025-3-24 06:50
Book 2014asing use of medical imaging in clinical trials, through all phases. More recently this has culminated in a number of inter-disciplinary meetings with the various stake holders, including the FDA.?Changes in the regulatory process has resulted, when it comes to the submission of data to the FDA, in 作者: lanugo 時(shí)間: 2025-3-24 13:51
Imaging in Musculoskeletal, Metabolic, Endocrinological, and Pediatric Clinical Trials This chapter will present the key disease areas, the imaging requirements, the characteristics, including the challenge of quantitative versus qualitative assessment, and the use of imaging as a biomarker in these diseases.作者: vascular 時(shí)間: 2025-3-24 15:31 作者: FRAUD 時(shí)間: 2025-3-24 22:25 作者: Free-Radical 時(shí)間: 2025-3-25 01:37 作者: BUCK 時(shí)間: 2025-3-25 04:21 作者: precede 時(shí)間: 2025-3-25 11:13 作者: 載貨清單 時(shí)間: 2025-3-25 13:39
Colin G. Miller BSc, PhD, FICR, CSciic ideas, bringing the reader to the cutting edge of current research. Part III presentscomplexity results and lower bounds, giving negative evidence by way of W[1]-hardness, the Exponential Time Hypothesis, and kernelization lower bounds..All the results and concepts are introduced at a level acces作者: Anthrp 時(shí)間: 2025-3-25 17:04
Robert C. Sergott MDdifferent methodologies used, namely the likelihood ratio criterion as well as?the Bayesian and information criterion approaches. New examples of change point analysis in modern molecular biology and other fields?such as finance and air traffic control?are added in this second edition.?Also included作者: averse 時(shí)間: 2025-3-25 22:03 作者: 有法律效應(yīng) 時(shí)間: 2025-3-26 03:54
Hendrik von Tengg-Kobligk MD, Dr. med., Priv-Doz,Amit Mehndiratta MBBS, DPhil (Oxon),Frederik L. Giedifferent methodologies used, namely the likelihood ratio criterion as well as?the Bayesian and information criterion approaches. New examples of change point analysis in modern molecular biology and other fields?such as finance and air traffic control?are added in this second edition.?Also included作者: 成份 時(shí)間: 2025-3-26 06:38 作者: 問(wèn)到了燒瓶 時(shí)間: 2025-3-26 10:05 作者: senile-dementia 時(shí)間: 2025-3-26 15:01 作者: 緩和 時(shí)間: 2025-3-26 17:58 作者: Mhc-Molecule 時(shí)間: 2025-3-26 22:36
mplexity results and lower bounds, giving negative evidence by way of W[1]-hardness, the Exponential Time Hypothesis, and kernelization lower bounds..All the results and concepts are introduced at a level acces978-3-319-35702-7978-3-319-21275-3作者: MURAL 時(shí)間: 2025-3-27 03:38 作者: Contracture 時(shí)間: 2025-3-27 07:49
Derek Pearson PhD, BScmplexity results and lower bounds, giving negative evidence by way of W[1]-hardness, the Exponential Time Hypothesis, and kernelization lower bounds..All the results and concepts are introduced at a level acces978-3-319-35702-7978-3-319-21275-3作者: Confirm 時(shí)間: 2025-3-27 10:45 作者: 山頂可休息 時(shí)間: 2025-3-27 16:18 作者: 胎兒 時(shí)間: 2025-3-27 18:38 作者: CLAN 時(shí)間: 2025-3-28 00:38 作者: animated 時(shí)間: 2025-3-28 06:07
with exercises and suggested reading, suitable for graduate.This comprehensive textbook presents a clean and coherent account of most fundamental tools and techniques in Parameterized Algorithms and is a self-contained guide to the area. The book covers many of the recent developments of the field,作者: IOTA 時(shí)間: 2025-3-28 09:43 作者: 抱怨 時(shí)間: 2025-3-28 11:50
Harris A. Ahmad MD,Hui Jing Yu PhD,Colin G. Miller BSc, PhD, FICR, CSci with exercises and suggested reading, suitable for graduate.This comprehensive textbook presents a clean and coherent account of most fundamental tools and techniques in Parameterized Algorithms and is a self-contained guide to the area. The book covers many of the recent developments of the field,作者: Arthr- 時(shí)間: 2025-3-28 15:50
Colin G. Miller BSc, PhD, FICR, CScicontained guide to the area. The book covers many of the recent developments of the field, including application of important separators, branching based on linear programming, Cut & Count to obtain faster algorithms on tree decompositions, algorithms based on representative families of matroids, an作者: 爭(zhēng)論 時(shí)間: 2025-3-28 22:49 作者: 提升 時(shí)間: 2025-3-29 02:26 作者: 同位素 時(shí)間: 2025-3-29 06:58
Colin G. Miller BSc, PhD, FICR, CScicontained guide to the area. The book covers many of the recent developments of the field, including application of important separators, branching based on linear programming, Cut & Count to obtain faster algorithms on tree decompositions, algorithms based on representative families of matroids, an作者: 朋黨派系 時(shí)間: 2025-3-29 09:03 作者: 類型 時(shí)間: 2025-3-29 11:48 作者: 徹底明白 時(shí)間: 2025-3-29 18:53
Hendrik von Tengg-Kobligk MD, Dr. med., Priv-Doz,Amit Mehndiratta MBBS, DPhil (Oxon),Frederik L. Gieion of change point analysis of the most commonly used statistical models. Change point problems are encountered in such disciplines as economics, finance, medicine, psychology, signal processing, and geology, to mention only several. More?recently, change point analysis has been found?in extensive 作者: 樂(lè)章 時(shí)間: 2025-3-29 23:10 作者: Defiance 時(shí)間: 2025-3-30 01:57 作者: 他姓手中拿著 時(shí)間: 2025-3-30 06:43 作者: organism 時(shí)間: 2025-3-30 10:31
The Metrics and New Imaging Marker Qualification in Medical Imaging Modalitiestic intervention. There are eight key metrics when evaluating a biomarker or imaging technique which has to be put into context with the key use of the system. This chapter will describe these key metrics in this context with particular emphasis of the use in clinical trials.作者: GOAT 時(shí)間: 2025-3-30 14:56
Radiation Risks and Dosimetry Assessmentnning stage and that the radiation risks are adequately explained as part of the informed consent process. It outlines the steps to take to assess the radiation dose, taking into account the potential variation between participating centres. It examines the risks associated with radiation exposure a作者: 法律 時(shí)間: 2025-3-30 17:08
Imaging Review Charters and Operational Considerationsre are FDA guidelines (albeit in draft at the time of writing and presented verbatim in Appendix 1 of this book), which detail the requirements and contents for the Imaging Review Charter (IRC). This chapter provides the historical perspective for these guidelines and details the contents that have 作者: 征兵 時(shí)間: 2025-3-30 23:19
Defining the Radiological Blinded Read and Adjudicationteam of radiologists and or physicians. There are three major kinds of blinded read: eligibility, safety, and efficacy, of which each of these is managed in a different manner. This chapter presents the various methodologies that are employed in blinded reads across phases of trials and between diff作者: 虛情假意 時(shí)間: 2025-3-31 02:53 作者: evince 時(shí)間: 2025-3-31 08:50
Monitoring Responses to Therapy in Oncology trials. The fate of a new drug should not be wrongfully determined because of imprecise assessment methods used in the clinical trial. Therefore, it is crucial to select the most appropriate response assessment method, which considers the mechanisms of interactions between drugs and cancers as well作者: hypnotic 時(shí)間: 2025-3-31 10:34 作者: 潛伏期 時(shí)間: 2025-3-31 15:24
